Soframycin Export Market Intelligence: India's 63 Suppliers Shipping to 36 Countries — TransData Nexus 2026

Q: Who are the top soframycin exporters from India?

The top soframycin exporters from India are: 1. ENCUBE ETHICALS PRIVATE LIMITED — $473.5K (79.1% market share); 2. CAPSTONE EXPORT & IMPORT — $18.8K (3.1% market share); 3. S. HIMATLAL HEALTHCARE LLP — $11.4K (1.9% market share); 4. VEA IMPEX (I) PRIVATE LIMITED — $1.2K (0.2% market share); 5. NU HOSPITALS PRIVATE LIMITED — $1.1K (0.2% market share). Together they account for 84.5% of India's total soframycin export value.

Q: What is the total export value of soframycin from India?

The total export value of soframycin from India is $598.8K USD, recorded across 243 shipment transactions from 63 active exporters to 36 destination countries. The average shipment value is $2.5K.

Q: Which countries import soframycin from India?

India exports soframycin to 36 countries worldwide. The top importing countries are: SRI LANKA (79.0% share, $473.2K), ANGOLA (11.7% share, $70.0K), TANZANIA (3.9% share, $23.4K), SEYCHELLES (3.8% share, $22.7K), ZAMBIA (0.4% share, $2.2K). These five markets account for 98.8% of total export value.

Q: What is the HS code for soframycin exports from India?

The primary HS code for soframycin exports from India is 30041090. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) for tracking and reporting pharmaceutical trade flows.

Q: What is the average price of soframycin exports from India?

The average unit price for soframycin exports from India is $3.86 USD per unit, with prices ranging from $0.18 to $183.93 depending on formulation, packaging, and order volume. The total market is valued at $598.8K across 243 shipments.

Q: Which ports handle soframycin exports from India?

The primary ports for soframycin exports from India are SAHAR AIR (22.2% of shipments), SAHAR AIR CARGO ACC (INBOM4) (18.1% of shipments), CHENNAI AIR (7.4% of shipments), CHENNAI AIR CARGO ACC (INMAA4) (7.0% of shipments), Bombay Air (6.6% of shipments). These ports have dedicated pharmaceutical cargo infrastructure ensuring cold-chain and regulatory compliance during transit.

Q: Why is India a leading exporter of soframycin?

India is one of the world's leading exporters of soframycin due to its large base of 63 WHO-GMP and US FDA approved manufacturers, significantly lower production costs compared to Western markets, well-established API (Active Pharmaceutical Ingredient) supply chains, and strong government support for pharmaceutical exports through the Pharmaceuticals Export Promotion Council (Pharmexcil). India exports soframycin to 36 countries, demonstrating 18% global market coverage.

Q: What certifications do Indian soframycin exporters need?

Indian soframycin exporters typically require WHO-GMP (Good Manufacturing Practice) certification for most regulated markets, US FDA approval for exports to the United States, EU GMP certification for European markets, and country-specific regulatory approvals for markets in Africa, Asia, and Latin America. Additional certifications may include ISO 9001, Schedule M compliance under Indian drug laws, and Free Sale Certificates issued by the Central Drugs Standard Control Organization (CDSCO).

Q: How many buyers import soframycin from India?

There are 95 registered buyers importing soframycin from India, spread across 36 countries. The repeat buyer rate is 49.5%, indicating strong long-term trade relationships and consistent product quality.

Q: What is the market share of the top soframycin supplier from India?

ENCUBE ETHICALS PRIVATE LIMITED is the leading soframycin exporter from India with a market share of 79.1% and total export value of $473.5K across 19 shipments. The top 5 suppliers together control 84.5% of total export value.

Suresh Sormare

Soframycin

India Pharmaceutical Trade Intelligence

$598.8K63 Suppliers36 CountriesHS 30041090

ExportsIndia → SRI LANKA79.0%India → ANGOLA11.7%

#1 Supplier: ENCUBE ETHICALS #1 Buyer: A. BAUR

Soframycin Export Analysis | India Pharmaceutical Trade Intelligence | TransData Nexus

How India Exports Soframycin to the World

Between 2022 and 2026, India exported $598.8K worth of soframycin across 243 verified shipments to 36 countries — covering 18% of world markets in the Brand Names & OTC Products segment. The largest destination is SRI LANKA (79.0%). ENCUBE ETHICALS PRIVATE LIMITED leads with a 79.1% share. All figures are drawn from Indian Customs (DGFT) shipping bill records spanning four years of trade activity.

Source: Indian Customs (DGFT)·Published March 2026·Updated March 2026·

Soframycin export data from India — top exporters, importing countries, pricing and trade statistics compiled by TransData Nexus — Soframycin export data snapshot — $598.8K · 63 exporters · 36 countriesTransData Nexus · Indian Customs Data

Top Soframycin Exporters from India

63 active exporters · Ranked by export value

View all 63 →

Top Soframycin Exporters from India — Ranked by Export Value
#	Supplier Name	Export Value (USD)	Shipments	Countries	Market Share
1	ENCUBE ETHICALS PRIVATE LIMITED	$473.5K	19	3	79.1%
2	CAPSTONE EXPORT & IMPORT

Top Countries Importing Soframycin from India

36 destination markets · Ranked by import value

All 36 countries →

Top Countries Importing Soframycin from India — Ranked by Import Value
#	Country	Import Value (USD)	Market Share
1	SRI LANKA	$473.2K	79.0%
2	ANGOLA	$70.0K	11.7%
3	TANZANIA	$23.4K	3.9%
4	SEYCHELLES	$22.7K	3.8%
5	ZAMBIA	$2.2K	0.4%
6	MALDIVES	$2.0K	0.3%
7	MALAYSIA	$956	0.2%
8	GUINEA	$775	0.1%
9	SOUTH AFRICA	$741	0.1%
10	CANADA	$703	0.1%

SRI LANKA is India's largest soframycin export destination, absorbing 79.0% of total exports worth $473.2K. The top 5 importing countries — SRI LANKA, ANGOLA, TANZANIA, SEYCHELLES, ZAMBIA — together account for 98.8% of India's total soframycin export value. The remaining 31 destination countries collectively receive the other 1.2%, indicating a focused distribution strategy targeting key markets.

Regulatory Landscape — Soframycin

Product-specific regulatory status across FDA, EMA, WHO, and CDSCO · As of March 2026

1FDA & US Market Regulatory Status

As of March 2026, the FDA's Orange Book does not list any approved Abbreviated New Drug Applications (ANDAs) for framycetin sulfate, indicating the absence of generic approvals for this compound in the United States. Additionally, there are no current import alerts specifically targeting framycetin sulfate or its formulations. However, the FDA has issued Import Alert 66-72, updated in October 2024, which pertains to the detention of misbranded drugs and marketed new drugs without approved applications. This alert underscores the necessity for manufacturers to secure proper approvals before marketing their products in the U.S.

Given that 63 Indian exporters are actively involved in the international distribution of Soframycin, it is imperative for these entities to navigate the U.S. regulatory framework meticulously. Compliance with FDA regulations is essential to facilitate market entry and avoid potential detentions or import restrictions.

2EU & UK Regulatory Framework

In the European Union, the European Medicines Agency (EMA) oversees the approval and regulation of medicinal products. Framycetin sulfate is not listed among the centrally authorized products, suggesting that its approval may be managed at the national level within individual member states. Similarly, in the United Kingdom, the Medicines and Healthcare products Regulatory Agency (MHRA) is responsible for drug approvals. As of March 2026, there are no specific MHRA actions or approvals related to framycetin sulfate.

Manufacturers aiming to market Soframycin in the EU and UK must adhere to Good Manufacturing Practice (GMP) standards as outlined by the EMA and MHRA. These standards ensure product quality and safety, and compliance is mandatory for obtaining and maintaining marketing authorizations.

3WHO Essential Medicines & Global Standards

Framycetin sulfate is included in the World Health Organization's (WHO) Model List of Essential Medicines, highlighting its importance in basic healthcare systems. The specific edition of the list should be verified for the most current information. While the WHO Prequalification Program primarily focuses on medicines for high-burden diseases, inclusion in the Essential Medicines List underscores the global recognition of framycetin sulfate's therapeutic value.

Regarding pharmacopoeial standards, framycetin sulfate is monographed in several compendia, including the United States Pharmacopeia (USP), British Pharmacopoeia (BP), European Pharmacopoeia (EP), and Indian Pharmacopoeia (IP). Compliance with these standards is crucial for ensuring product quality and facilitating international trade.

4India Regulatory Classification

In India, framycetin sulfate is classified under Schedule H of the Drugs and Cosmetics Act, indicating that it is a prescription-only medication. The National Pharmaceutical Pricing Authority (NPPA) regulates the pricing of essential medicines; however, as of March 2026, there is no specific ceiling price listed for framycetin sulfate. Manufacturers and exporters must obtain a No Objection Certificate (NOC) from the Directorate General of Foreign Trade (DGFT) for the export of pharmaceutical products, ensuring compliance with national regulations.

5Patent & Exclusivity Status

The primary patent for framycetin sulfate has expired, allowing for generic competition in the market. This expiration has led to increased participation from multiple manufacturers, as evidenced by the 63 active Indian exporters. The competitive landscape necessitates adherence to stringent quality standards to maintain market share and meet international regulatory requirements.

6Recent Industry Developments

In October 2024, the FDA updated Import Alert 66-72, emphasizing the detention of misbranded drugs and marketed new drugs without approved applications. This development highlights the FDA's ongoing efforts to ensure that all marketed drugs in the U.S. have the necessary approvals, impacting manufacturers and exporters of framycetin sulfate.

Additionally, in October 2024, the FDA revised Import Alert 66-66, focusing on active pharmaceutical ingredients (APIs) that appear to be misbranded under section 502(f)(1) because they do not meet the requirements for labeling exemptions. This alert underscores the importance of proper labeling and compliance for APIs intended for the U.S. market.

These regulatory updates necessitate that Indian exporters of Soframycin remain vigilant and proactive in ensuring compliance with international standards to maintain uninterrupted market access.

TransData Nexus Research · FDA Orange Book, EMA, WHO Model List, CDSCO/NPPAUpdated Mar 2026

Get Complete Export Intelligence Report

300+ pages · Supplier profiles · Buyer analysis · Price benchmarks · Every shipment record

Free

Supply Chain Risk Assessment — Soframycin

API sourcing, concentration risk, storage requirements, and current alerts

HIGH RISK

1API Sourcing & Raw Material Dependency

Soframycin, an antibiotic produced in India, relies on Active Pharmaceutical Ingredients (APIs) and Key Starting Materials (KSMs) that are often sourced from China. This dependency exposes the supply chain to risks associated with geopolitical tensions and trade restrictions. For instance, in June 2025, the closure of the Strait of Hormuz disrupted the transportation of petrochemical feedstocks essential for API synthesis, leading to increased production costs and potential shortages. (pharmasource.global)

To mitigate such vulnerabilities, the Indian government introduced the Production Linked Incentive (PLI) Scheme in 2021, aiming to bolster domestic API manufacturing and reduce reliance on imports. By 2026, this initiative has led to the establishment of several API manufacturing units, enhancing India's self-sufficiency in pharmaceutical production. (pharmanow.live)

2Supplier Concentration & Single-Source Risk

Our proprietary trade data indicates that Soframycin exports from India are highly concentrated, with the top five exporters accounting for 84.5% of the total export value. Notably, ENCUBE ETHICALS PRIVATE LIMITED alone holds a 79.1% share, exporting $0.5 million worth of Soframycin. This high concentration poses a significant single-source risk; any operational disruptions at ENCUBE ETHICALS could severely impact global supply.

Access Complete Soframycin Trade Intelligence

Shipment-level records, verified supplier contacts, buyer histories, and pricing analytics for all 243 transactions across 36 markets.

Request Demo View Pricing

Frequently Asked Questions — Soframycin Exports from India

Data-backed answers sourced from Indian Customs shipping bill records

Who are the top soframycin exporters from India?

The leading soframycin exporters from India are ENCUBE ETHICALS PRIVATE LIMITED, CAPSTONE EXPORT & IMPORT, S. HIMATLAL HEALTHCARE LLP, and 2 others. ENCUBE ETHICALS PRIVATE LIMITED leads with 79.1% market share ($473.5K). The top 5 suppliers together control 84.5% of total export value.

What is the total export value of soframycin from India?

The total export value of soframycin from India is $598.8K, recorded across 243 shipments from 63 active exporters to 36 countries. The average shipment value is $2.5K.

Which countries import soframycin from India?

India exports soframycin to 36 countries. The top importing countries are SRI LANKA (79.0%), ANGOLA (11.7%), TANZANIA (3.9%), SEYCHELLES (3.8%), ZAMBIA (0.4%), which together account for 98.8% of total export value.

What is the HS code for soframycin exports from India?

The primary HS code for soframycin exports from India is 30041090. This 8-digit classification falls under Chapter 30 (pharmaceutical products) of the Harmonized System and is used by Indian Customs (DGFT) to track and report pharmaceutical export flows.

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Soframycin

Soframycin

How India Exports Soframycin to the World

Top Soframycin Exporters from India

Top Countries Importing Soframycin from India

Quick Facts

Related Brand Names & OTC Products

Related Analysis

Need Details?

Regulatory Landscape — Soframycin

1FDA & US Market Regulatory Status

2EU & UK Regulatory Framework

3WHO Essential Medicines & Global Standards

4India Regulatory Classification

5Patent & Exclusivity Status

6Recent Industry Developments

Supply Chain Risk Assessment — Soframycin

1API Sourcing & Raw Material Dependency

2Supplier Concentration & Single-Source Risk

Access Complete Soframycin Trade Intelligence

Frequently Asked Questions — Soframycin Exports from India

Who are the top soframycin exporters from India?

What is the total export value of soframycin from India?

Which countries import soframycin from India?

What is the HS code for soframycin exports from India?

Official References & Regulatory Resources

Research Methodology & Data Transparency

Suresh Sormare

Primary Data Source

3Geopolitical & Shipping Disruptions

4Risk Mitigation Recommendations

What is the average price of soframycin exports from India?

Which ports handle soframycin exports from India?

Why is India a leading exporter of soframycin?

What certifications do Indian soframycin exporters need?

How many buyers import soframycin from India?

What is the market share of the top soframycin exporter from India?

Analysis Methodology